Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.49−0.21 (-2.41%)
Close on Nov 17, 2026Market cap $1.55BP/E –Yield –
Teladoc Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Teladoc Health's profit margin for the twelve months ending Sep 30, 2026 was -6.3%. For fiscal 2025 it was -7.9%, against -39.0% the year before. The highest annual figure on record is -7.9% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7.9% | +31.0 |
| FY2024 | Dec 31, 2024 | -39.0% | −30.5 |
| FY2023 | Dec 31, 2023 | -8.5% | +559.1 |
| FY2022 | Dec 31, 2022 | -567.5% | −546.4 |
| FY2021 | Dec 31, 2021 | -21.1% | +23.3 |
| FY2020 | Dec 31, 2020 | -44.3% | −26.5 |
| FY2019 | Dec 31, 2019 | -17.9% | +5.4 |
| FY2018 | Dec 31, 2018 | -23.2% | +22.5 |
| FY2017 | Dec 31, 2017 | -45.8% | +14.5 |
| FY2016 | Dec 31, 2016 | -60.3% | +14.7 |
| FY2015 | Dec 31, 2015 | -75.0% | −35.8 |
| FY2014 | Dec 31, 2014 | -39.1% | −8.9 |
| FY2013 | Dec 31, 2013 | -30.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -4.5% | +3.5 |
| Q2 FY2026 | Jun 30, 2026 | -6.4% | −1.2 |
| Q1 FY2026 | Mar 31, 2026 | -10.4% | +4.4 |
| Q4 FY2025 | Dec 31, 2025 | -3.9% | +3.6 |
| Q3 FY2025 | Sep 30, 2025 | -7.9% | −2.7 |
| Q2 FY2025 | Jun 30, 2025 | -5.2% | +125.2 |
| Q1 FY2025 | Mar 31, 2025 | -14.8% | −2.1 |
| Q4 FY2024 | Dec 31, 2024 | -7.6% | −3.2 |
| Q3 FY2024 | Sep 30, 2024 | -5.2% | +3.4 |
| Q2 FY2024 | Jun 30, 2024 | -130.4% | −120.4 |
| Q1 FY2024 | Mar 31, 2024 | -12.7% | −1.7 |
| Q4 FY2023 | Dec 31, 2023 | -4.4% | +593.1 |
| Q3 FY2023 | Sep 30, 2023 | -8.6% | +3.4 |
| Q2 FY2023 | Jun 30, 2023 | -10.0% | +513.6 |
| Q1 FY2023 | Mar 31, 2023 | -11.0% | +1169.6 |
| Q4 FY2022 | Dec 31, 2022 | -597.5% | −595.5 |
| Q3 FY2022 | Sep 30, 2022 | -12.0% | +4.2 |
| Q2 FY2022 | Jun 30, 2022 | -523.6% | −497.0 |
| Q1 FY2022 | Mar 31, 2022 | -1180.6% | −1136.6 |
| Q4 FY2021 | Dec 31, 2021 | -2.0% | +100.8 |
| Q3 FY2021 | Sep 30, 2021 | -16.2% | −3.7 |
| Q2 FY2021 | Jun 30, 2021 | -26.6% | −15.9 |
| Q1 FY2021 | Mar 31, 2021 | -44.0% | −27.6 |
| Q4 FY2020 | Dec 31, 2020 | -102.8% | −90.6 |
| Q3 FY2020 | Sep 30, 2020 | -12.4% | +2.3 |
| Q2 FY2020 | Jun 30, 2020 | -10.7% | +11.9 |
| Q1 FY2020 | Mar 31, 2020 | -16.4% | +7.1 |
| Q4 FY2019 | Dec 31, 2019 | -12.2% | +8.1 |
| Q3 FY2019 | Sep 30, 2019 | -14.7% | +6.2 |
| Q2 FY2019 | Jun 30, 2019 | -22.5% | +4.0 |
| Q1 FY2019 | Mar 31, 2019 | -23.4% | +3.2 |
| Q4 FY2018 | Dec 31, 2018 | -20.3% | +37.3 |
| Q3 FY2018 | Sep 30, 2018 | -21.0% | +24.7 |
| Q2 FY2018 | Jun 30, 2018 | -26.5% | +8.0 |
| Q1 FY2018 | Mar 31, 2018 | -26.6% | +9.9 |
| Q4 FY2017 | Dec 31, 2017 | -57.5% | −19.4 |
| Q3 FY2017 | Sep 30, 2017 | -45.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -34.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -36.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -38.1% | – |
See a number that looks wrong?